trial · primary record
SPN-821 2400 mg
Major Depressive Disorder (MDD)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 230 |
| Primary completion | 2027-01-31 |
| Primary endpoint | Change From Baseline to Day 29 in the Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score. |
| Registry ID | NCT07226661 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:51.245Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07226661
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.